Merck board to consider financial results

17 Jul 2012 Evaluate
Merck has informed that a meeting of the board of directors of the company will be held on July 23, 2012, to consider and approve the unaudited financial results for the second quarter and half year ended June 30, 2012 & also to consider the appointment of Claus-Dieter Boedecker as managing director of the company with effect from August 01, 2012 in place of Marek Dziki whose term of appointment is expiring on July 31, 2012.

The above information is a part of company's filings submitted to BSE.

Procter&Gamble Healt Share Price

4792.00 42.75 (0.90%)
15-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.